Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

86,510 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Intracavitary Balloon Catheter Brain Brachytherapy for Malignant Gliomas or Metastasis to the BrainPayerPolicy · ARKBLUE-INTRACAVITARY-BALLOON-CATHETER-BRAIN-BRACHYTHERAPY-FOR-MALIGNANT-GLIOMAS-OR-METASTASIS-TO-THE-BRAIN	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Intra-articular Hyaluronan Injections for OsteoarthritisPayerPolicy · ARKBLUE-INTRA-ARTICULAR-HYALURONAN-INJECTIONS-FOR-OSTEOARTHRITIS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Interventions for Progressive ScoliosisPayerPolicy · ARKBLUE-INTERVENTIONS-FOR-PROGRESSIVE-SCOLIOSIS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)PayerPolicy · ARKBLUE-INTERSPINOUS-AND-INTERLAMINAR-STABILIZATION-DISTRACTION-DEVICES-SPACERS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Intensity Modulated Radiation Therapy (IMRT): Head and Neck, Thyroid, Central Nervous System, and Other MalignanciesPayerPolicy · ARKBLUE-INTENSITY-MODULATED-RADIATION-THERAPY-IMRT-HEAD-AND-NECK-THYROID-CENTRAL-NERVOUS-SYSTEM-AND-OTHER-MALIGNANCIES	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Non-Implantable Insulin Infusion Devices, Hybrid Insulin Infusion Devices, and Continuous Glucose Monitoring DevicesPayerPolicy · ARKBLUE-NON-IMPLANTABLE-INSULIN-INFUSION-DEVICES-HYBRID-INSULIN-INFUSION-DEVICES-AND-CONTINUOUS-GLUCOSE-MONITORING-DEVICES	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Inotuzumab Ozogamicin (e.g., Besponsa)PayerPolicy · ARKBLUE-INOTUZUMAB-OZOGAMICIN-E-G-BESPONSATM	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Injection, Clostridial Collagenase for Fibroproliferative DisordersPayerPolicy · ARKBLUE-INJECTION-CLOSTRIDIAL-COLLAGENASE-FOR-FIBROPROLIFERATIVE-DISORDERS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Gene Therapy for Inherited Retinal Dystrophy-Voretigene (e.g., Luxturna)PayerPolicy · ARKBLUE-GENE-THERAPY-FOR-INHERITED-RETINAL-DYSTROPHY-VORETIGENE-E-G-LUXTURNA	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Ingestible pH and Pressure Capsule and Gastric Emptying Breath TestingPayerPolicy · ARKBLUE-INGESTIBLE-PH-AND-PRESSURE-CAPSULE-AND-GASTRIC-EMPTYING-BREATH-TESTING	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Infliximab (e.g., Remicade and Unbranded Infliximab) and BiosimilarsPayerPolicy · ARKBLUE-INFLIXIMAB-E-G-REMICADE-AND-UNBRANDED-INFLIXIMAB-AND-BIOSIMILARS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Infertility ServicesPayerPolicy · ARKBLUE-INFERTILITY-SERVICES	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Inebilizumab-cdon (e.g., Uplizna)PayerPolicy · ARKBLUE-INEBILIZUMAB-CDON-E-G-UPLIZNA	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Inclisiran (e.g., Leqvio)PayerPolicy · ARKBLUE-INCLISIRAN-E-G-LEQVIO	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Intensity Modulated Radiation Therapy (IMRT), Abdomen and PelvisPayerPolicy · ARKBLUE-INTENSITY-MODULATED-RADIATION-THERAPY-IMRT-ABDOMEN-AND-PELVIS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Intensity Modulated Radiation Therapy (IMRT), ProstatePayerPolicy · ARKBLUE-INTENSITY-MODULATED-RADIATION-THERAPY-IMRT-PROSTATE	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Intensity Modulated Radiotherapy of the Chest (Breast, Lung, Esophagus, and Mediastinum)PayerPolicy · ARKBLUE-INTENSITY-MODULATED-RADIOTHERAPY-OF-THE-CHEST-BREAST-LUNG-ESOPHAGUS-AND-MEDIASTINUM	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Implantable Telescope for the Treatment of Age-Related Macular DegenerationPayerPolicy · ARKBLUE-IMPLANTABLE-TELESCOPE-FOR-THE-TREATMENT-OF-AGE-RELATED-MACULAR-DEGENERATION	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Implantable Infusion PumpPayerPolicy · ARKBLUE-IMPLANTABLE-INFUSION-PUMP	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Implantable Bone Conduction Hearing AidsPayerPolicy · ARKBLUE-IMPLANTABLE-BONE-CONDUCTION-HEARING-AIDS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Immune Globulin, Primary and Secondary ImmunodeficienciesPayerPolicy · ARKBLUE-IMMUNE-GLOBULIN-PRIMARY-AND-SECONDARY-IMMUNODEFICIENCIES	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Immune Globulin, Autoimmune, Rheumatic and Neurologic IndicationsPayerPolicy · ARKBLUE-IMMUNE-GLOBULIN-AUTOIMMUNE-RHEUMATIC-AND-NEUROLOGIC-INDICATIONS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Immune Globulin- Hematologic, Transplant, Infectious Disease and Miscellaneous IndicationsPayerPolicy · ARKBLUE-IMMUNE-GLOBULIN-HEMATOLOGIC-TRANSPLANT-INFECTIOUS-DISEASE-AND-MISCELLANEOUS-INDICATIONS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Immune Cell Function AssayPayerPolicy · ARKBLUE-IMMUNE-CELL-FUNCTION-ASSAY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Immobilized lipase cartridge for enteral feedings (e.g., Relizorb)PayerPolicy · ARKBLUE-IMMOBILIZED-LIPASE-CARTRIDGE-FOR-ENTERAL-FEEDINGS-E-G-RELIZORB	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Imetelstat (e.g., Rytelo)PayerPolicy · ARKBLUE-IMETELSTAT-E-G-RYTELO	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Image Guided Radiation Therapy (IGRT)PayerPolicy · ARKBLUE-IMAGE-GUIDED-RADIATION-THERAPY-IGRT	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Idecabtagene Vicleucel (e.g., Abecma)PayerPolicy · ARKBLUE-IDECABTAGENE-VICLEUCEL-E-G-ABECMA	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hysteroscopic Placement of Micro-Inserts in the Fallopian Tubes as a Form of Permanent SterilizationPayerPolicy · ARKBLUE-HYSTEROSCOPIC-PLACEMENT-OF-MICRO-INSERTS-IN-THE-FALLOPIAN-TUBES-AS-A-FORM-OF-PERMANENT-STERILIZATION	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hyperhidrosis TreatmentPayerPolicy · ARKBLUE-HYPERHIDROSIS-TREATMENT	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hyperbaric Oxygen Pressurization (HBO)PayerPolicy · ARKBLUE-HYPERBARIC-OXYGEN-PRESSURIZATION-HBO	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hydrogel Implant for Prostate Radiation Therapy-Absorbable Perirectal Spacer (APS); SpaceOAR System (Augmenix inc)PayerPolicy · ARKBLUE-HYDROGEL-IMPLANT-FOR-PROSTATE-RADIATION-THERAPY-ABSORBABLE-PERIRECTAL-SPACER-APS-SPACEOAR-SYSTEM-AUGMENIX-INC	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Human Papilloma Virus Testing of Cervical Pap SmearsPayerPolicy · ARKBLUE-HUMAN-PAPILLOMA-VIRUS-TESTING-OF-CERVICAL-PAP-SMEARS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hematopoietic Stem Cell Transplantation (HSCT) for Multiple Myeloma and POEMS SyndromePayerPolicy · ARKBLUE-HEMATOPOIETIC-STEM-CELL-TRANSPLANTATION-HSCT-FOR-MULTIPLE-MYELOMA-AND-POEMS-SYNDROME	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hormone Pellet Implantation for Hormone TherapyPayerPolicy · ARKBLUE-HORMONE-PELLET-IMPLANTATION-FOR-HORMONE-THERAPY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Homocysteine MeasurementPayerPolicy · ARKBLUE-HOMOCYSTEINE-MEASUREMENT	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Home Cardiorespiratory MonitoringPayerPolicy · ARKBLUE-HOME-CARDIORESPIRATORY-MONITORING	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Histrelin Implant (e.g., Supprelin LA)PayerPolicy · ARKBLUE-HISTRELIN-IMPLANT-E-G-SUPPRELIN-LA	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	HippotherapyPayerPolicy · ARKBLUE-HIPPOTHERAPY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hip ResurfacingPayerPolicy · ARKBLUE-HIP-RESURFACING	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hereditary Angioedema (HAE) with normal C1 inhibitor levels, Prophylaxis and Acute TreatmentPayerPolicy · ARKBLUE-HEREDITARY-ANGIOEDEMA-HAE-WITH-NORMAL-C1-INHIBITOR-LEVELS-PROPHYLAXIS-AND-ACUTE-TREATMENT	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hereditary Angioedema (HAE) with deficient or dysfunctional C1 inhibitor (C1INH), Prophylaxis and Acute TreatmentPayerPolicy · ARKBLUE-HEREDITARY-ANGIOEDEMA-HAE-WITH-DEFICIENT-OR-DYSFUNCTIONAL-C1-INHIBITOR-C1INH-PROPHYLAXIS-AND-ACUTE-TREATMENT	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hepatic Tumors, Ablative Procedures (Percutaneous Ethanol Injections, Acetic Acid Injections, and Interstitial Laser Photocoagulation)PayerPolicy · ARKBLUE-HEPATIC-TUMORS-ABLATIVE-PROCEDURES-PERCUTANEOUS-ETHANOL-INJECTIONS-ACETIC-ACID-INJECTIONS-AND-INTERSTITIAL-LASER-PHOTOCOAGULATION	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Hemodynamic Monitoring of Heart Failure, Management in the Outpatient SettingPayerPolicy · ARKBLUE-HEMODYNAMIC-MONITORING-OF-HEART-FAILURE-MANAGEMENT-IN-THE-OUTPATIENT-SETTING	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	HDC & Progenitor Cell Support AL Amyloidosis (Light Chain Amyloidosis)PayerPolicy · ARKBLUE-HDC-PROGENITOR-CELL-SUPPORT-AL-AMYLOIDOSIS-LIGHT-CHAIN-AMYLOIDOSIS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	HDC & Hematopoietic Stem Cell Support-Miscellaneous Solid Tumors in AdultsPayerPolicy · ARKBLUE-HDC-HEMATOPOIETIC-STEM-CELL-SUPPORT-MISCELLANEOUS-SOLID-TUMORS-IN-ADULTS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	HDC & Hematopoietic Stem Cell Support-Autoimmune Diseases, Including Multiple SclerosisPayerPolicy · ARKBLUE-HDC-HEMATOPOIETIC-STEM-CELL-SUPPORT-AUTOIMMUNE-DISEASES-INCLUDING-MULTIPLE-SCLEROSIS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	HDC & Hematopoietic Stem Cell Support for Breast CancerPayerPolicy · ARKBLUE-HDC-HEMATOPOIETIC-STEM-CELL-SUPPORT-FOR-BREAST-CANCER	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	HDC & Autologous or Allogeneic Cell Transplantation-Epithelial Ovarian CancerPayerPolicy · ARKBLUE-HDC-AUTOLOGOUS-OR-ALLOGENEIC-CELL-TRANSPLANTATION-EPITHELIAL-OVARIAN-CANCER	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	HDC & Autologous Stem &/or Progenitor Cell Support-Waldenstrom's MacroglobulinemiaPayerPolicy · ARKBLUE-HDC-AUTOLOGOUS-STEM-OR-PROGENITOR-CELL-SUPPORT-WALDENSTROM-S-MACROGLOBULINEMIA	New policy